Inventor · disambiguated record
Oliver Martin Fischer
Also filed as: FISCHER OLIVER · FISCHER OLIVER MARTIN
9 granted patents·9 pending applications·17 citations·filing 2003–2021
82Inventor score
Top patents by PatentIndex Score
18 records- 0190US10202369B21,3-thiazol-2-yl substituted benzamidesBAYER AG·Filed 2017·Granted Feb 12, 2019·4 cites·26 claims
- 0289US10472354B21,3-thiazol-2-yl substituted benzamidesBAYER AG·Filed 2018·Granted Nov 12, 2019·3 cites·13 claims
- 0389US10174016B21,3-thiazol-2-yl substituted benzamidesBAYER AG·Filed 2015·Granted Jan 8, 2019·4 cites·34 claims
- 0486US11142523B21,3-thiazol-2-yl substituted benzamidesBAYER AG·Filed 2019·Granted Oct 12, 2021·2 cites·16 claims
- 0581US10183937B21,3-thiazol-2-yl substituted benzamidesBAYER AG·Filed 2017·Granted Jan 22, 2019·4 cites·22 claims
- 0673US2023053411A11,3-thiazol-2-yl substituted benzamidesBAYER AG·Filed 2021·Application pending·0 cites
- 0753US2006148694A1Inhibition of stress-induced ligand-dependent egfr activationMAX PLANCK GESELLSCHAFT·Filed 2004·Application pending·0 cites
- 0848US2023013419A1Analogues of 3-(5-methyl-1,3-thiazol-2-yl)-n-{(1r)-1-[2-(trifluoro-methyl)pyrimidin-5-yl]ethyl}benzamideBAYER AG·Filed 2020·Application pending·0 cites
- 0947US2022249458A1Agonists Of AdiponectinBAYER AG·Filed 2020·Application pending·0 cites
- 1043US2011003778A1Mineralcorticoid receptor antagonists for the treatment of endometriosisBAYER SCHERING PHARMA AG·Filed 2008·Application pending·0 cites
- 1142US2005176633A1Use of egfr transactivation inhibitors in human cancerFiled 2003·Application pending·0 cites
- 1240US11319324B2Pyrazolo-pyrrolo-pyrimidine-dione derivatives as P2X3 inhibitorsBAYER AG·Filed 2018·Granted May 3, 2022·0 cites·11 claims
- 1340US9714266B2Estra-1,3,5(10),16-tetraene-3-carboxamides for inhibition of 17.beta.-hydroxysteroid dehydrogenase (AKR1C3)Bayer Pharma AG·Filed 2014·Granted Jul 25, 2017·0 cites·10 claims
- 1439US9512169B23-substituted estra-1,3,5(10),16-tetraene derivatives, methods for the production thereof, pharmaceutical preparations containing same, and use thereof for the production of medicamentsBayer Pharma AG·Filed 2013·Granted Dec 6, 2016·0 cites·10 claims
- 1539US2021220357A11,3-thiazol-2-yl substituted benzamides for the treatment of diseases associated with nerve fiber sensitizationBAYER AG·Filed 2019·Application pending·0 cites
- 1638US2021220358A11,3-thiazol-2-yl substituted benzamides for the treatment of diseases associated with nerve fiber sensitizationBAYER AG·Filed 2019·Application pending·0 cites
- 1736US9487554B2Estra-1,3,5(10),16-tetraene-3-carboxamide derivatives, processes for their preparation, pharmaceutical preparations comprising them and their use for preparing medicamentsBAYER IP GMBH·Filed 2012·Granted Nov 8, 2016·0 cites·8 claims
- 1835US2014288035A118-methyl-6,7-methylene-3-oxo-17-pregn-4-ene-21,17b-carbolactones, pharmaceutical preparations comprising said compounds and use thereof in the treatment of endometriosisBAYER IP GMBH·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →